Insider Ownership Details

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.

Name Shares Options
Clarus Lifesciences II, L.P. 2,752,488 0
GALAKATOS NICHOLAS 2,752,488 6,500
Laufer Ron 1,632,652 11,094
MedImmune Ventures, Inc. 1,632,652 0
PERCEPTIVE ADVISORS LLC 1,038,309 0
George Jean 90,764 14,000
SVLSF V, LLC 59,139 0
Komjathy Andrew 100 55,000
Violin Jonathan 0 85,000
ADELMAN BURT A 0 7,500
ROSS MICHAEL JAY 0 14,000
Cole Hugh M 0 100,000
LAPOINTE ANTHONY GREGG 0 100,000
Callori Fred By Perceptive Xontogeny Venture Fund, LP 0 0
Modi Rick 0 45,000
Violin Jonathan By Lazarus Life Sciences I, LLC 0 0
BATE KENNETH 0 100,000
Callori Fred 0 85,000
Beck Joanne T. 0 100,000
Callori Fred By Xontogeny, LLC 0 0
Sanderson Ian C. 0 52,000
EDELMAN JOSEPH 0 0
Hibben Edward K. 0 100,000
Milne Jill C. 0 195,000
Harshbarger Benjamin 0 55,000
Cunnane Deirdre A. 0 40,000
0 0
Clauser Noah 0 55,000
Nichols Andrew John 0 55,000
KISHBAUCH MICHAEL D 0 100,000
Jirousek Michael 0 0
Donovan Joanne M. 0 60,000
 

While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price

Recent Insider Sales

Name Shares Price Date
 

Recent Insider Purchases

Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.

Name Shares Price Date